Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ruth, Baak"'
Autor:
Matthew Campbell, Karen E. Weck, Barbara A. Zehnbauer, Alan H.B. Wu, Arlene Buller, Ken Butz, Junaid Shabbeer, Jean Amos Wilson, Kasinathan Muralidharan, Ruth Baak, Milhan Telatar, Le Anne Noll, Tara L. Sander, Markus Zeller, Chris J. Civalier, Nikolina Babic, Maria P. Bettinotti, Carlos Vance, Elaine Lyon, Victoria M. Pratt, Daniel H. Farkas, Kiang-Teck J. Yeo, Jason McKinney, Lorraine Toji, Lisa V. Kalman, Chingying Huang Smith, Abdalla El-Badry, Saptarshi Mandal, Anand Vairavan
Publikováno v:
The Journal of Molecular Diagnostics. 12:835-846
Pharmacogenetic testing is becoming more common; however, very few quality control and other reference materials that cover alleles commonly included in such assays are currently available. To address these needs, the Centers for Disease Control and
Autor:
Patrick Gladding, Ruth Baak, John A. Ormiston, Peter Ruygrok, James T. Stewart, Mark Webster, Harvey D. White, Catherine White, Badi Bvaldivia, J. Voss
Publikováno v:
JACC: Cardiovascular Interventions. 2(11):1095-1101
Objectives Our aim was to assess whether a higher clopidogrel maintenance dose has a greater antiplatelet effect in CYP2C19*2 allele carriers compared with noncarriers. Background Clopidogrel is a prodrug that is biotransformed by the cytochrome P450
Autor:
Victoria M, Pratt, Barbara, Zehnbauer, Jean Amos, Wilson, Ruth, Baak, Nikolina, Babic, Maria, Bettinotti, Arlene, Buller, Ken, Butz, Matthew, Campbell, Chris, Civalier, Abdalla, El-Badry, Daniel H, Farkas, Elaine, Lyon, Saptarshi, Mandal, Jason, McKinney, Kasinathan, Muralidharan, LeAnne, Noll, Tara, Sander, Junaid, Shabbeer, Chingying, Smith, Milhan, Telatar, Lorraine, Toji, Anand, Vairavan, Carlos, Vance, Karen E, Weck, Alan H B, Wu, Kiang-Teck J, Yeo, Markus, Zeller, Lisa, Kalman
Pharmacogenetic testing is becoming more common; however, very few quality control and other reference materials that cover alleles commonly included in such assays are currently available. To address these needs, the Centers for Disease Control and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16603f93a9eb26a8b70bc0447a94c629
Autor:
Patrick, Gladding, Harvey, White, Jamie, Voss, John, Ormiston, Jim, Stewart, Peter, Ruygrok, Badi, Bvaldivia, Ruth, Baak, Catherine, White, Mark, Webster
Publikováno v:
JACC. Cardiovascular interventions. 2(11)
Our aim was to assess whether a higher clopidogrel maintenance dose has a greater antiplatelet effect in CYP2C19*2 allele carriers compared with noncarriers.Clopidogrel is a prodrug that is biotransformed by the cytochrome P450 enzymes CYP2C19, 2C9,